Entegris ENTG Stock Climbs As EUV, AI Tailwinds Build

Entegris Inc. stocks have been trading up by 12.16 percent following upbeat news signaling stronger semiconductor demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading ENTG

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Cross-licensing deal with JSR and Inpria gives Entegris a stronger footing in EUV metal oxide resist patents and removes a live patent challenge overhang.
Mizuho raised its ENTG price target to $180, kept an Outperform rating, and called Entegris one of the best-positioned materials players for the wafer fab equipment upcycle.
Insider sales from a senior vice president and a director totaled about $1.53M, but both still retain meaningful ENTG stakes.
Recent Form 3 and Form 4 filings show steady insider and large-holder activity around Entegris without clear directional signals.

Live Update At 14:02:52 EDT: On Thursday, June 18, 2026 Entegris Inc. stock [NASDAQ: ENTG] is trending up by 12.16%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

ENTG has been on a strong run. In mid-May, Entegris was chopping around the mid-$130s to low-$140s. By 2026/06/18, the stock closed at $176.65 after hitting an intraday high of $178.05. That is a powerful multi-week trend, with a series of higher lows from roughly $125 to the mid-$170s. For short-term traders, this is what a momentum staircase looks like.

Intraday, ENTG’s 5‑minute chart shows tight grinding action from the mid-$160s out of the open to the high‑$170s in the afternoon. Dips toward $170 kept getting bought, which tells traders there is real demand backing this move, not just a quick squeeze.

More Breaking News

Fundamentally, Entegris is a high-multiple growth name. ENTG trades at a price/earnings ratio around 81, with price-to-sales of 6.65 and enterprise value near $27.3B. Gross margin at 44.6% and EBITDA margin at 26.5% show a solid, profitable materials platform. Q1 revenue of about $812M and net income of $92M translate to roughly 11% EBIT margin. Free cash flow of $141.5M for the quarter and a current ratio of 3.2 give Entegris room to keep funding growth, even with total debt-to-equity near 0.93. For traders, this is a classic quality growth chart backed by real cash flow.

Why Traders Are Watching ENTG Right Now

Entegris is suddenly front and center in the AI semiconductor build‑out story, and that is why ENTG has become a momentum magnet. The key catalyst is the non‑exclusive cross‑licensing deal with JSR and Inpria around metal oxide resist patents for EUV lithography. This agreement does two important things at once for Entegris and ENTG traders.

First, it ends an active patent challenge, clearing legal noise that can scare away big funds and short‑term momentum traders alike. Removing that overhang lets the market focus on business, not courtrooms. Second, it ties Entegris directly into a broader collaboration on next‑generation EUV photoresist materials, plus related filtration and handling systems. Those are exactly the consumables needed for advanced nodes and AI‑era chips.

When fabs ramp wafer fab equipment spending, the materials suppliers with the right tech stack win. Mizuho leaned into that point by raising its ENTG price target to $180 from $175 and reiterating an Outperform rating. The firm highlighted Entegris as one of the best‑positioned materials suppliers for the current wafer fab equipment upcycle. Put simply, major Wall Street research is now aligned with the chart: ENTG is being treated as a prime way to ride the AI and advanced‑node build‑out.

Against that bullish backdrop, some traders are eyeing the recent insider sales. A senior vice president sold 6,848 ENTG shares for roughly $1.02M and still holds 54,961 shares. Director James P. Lederer sold 3,569 shares for about $512,000 at around $141.24 and still holds 18,277 shares. These look like standard profit‑taking moves after a strong run, not “abandon ship” behavior. Add in a new Form 3 showing a fresh insider or large holder and additional Form 4 activity, and you get a picture of normal governance churn rather than a red flag. For active ENTG traders, the bigger story remains the EUV deal and the bullish analyst stance.

Conclusion

ENTG is trading like a stock with real momentum and a real story. The cross‑licensing deal with JSR and Inpria locks Entegris into the EUV and AI manufacturing value chain while ending a patent dispute that could have turned ugly. Mizuho’s higher $180 price target and Outperform call add fuel, signaling that at least one major firm sees more upside as the wafer fab equipment cycle strengthens.

On the numbers, Entegris shows the mix many growth‑oriented traders look for: healthy gross margins, expanding free cash flow, and enough liquidity to keep funding new technology, even with a leveraged balance sheet. The flip side is that ENTG’s valuation is rich. An 80‑plus P/E and premium price‑to‑sales multiple mean this is not a bargain bin play. It is a momentum name that needs the AI and advanced‑node narrative to keep working.

That is where discipline comes in. Insider sales and high multiples remind traders that ENTG can pull back hard if sentiment shifts or the WFE upcycle stalls. As Tim Sykes likes to say, “The market doesn’t care about your opinion, it only cares about price action and risk management.” As Tim Bohen, lead trainer with StocksToTrade says, “There’s a pattern in everything; you just have to stick around long enough to see it.” For active traders, ENTG is a textbook case study: respect the uptrend, track the catalysts, and always plan your exit before you enter. This analysis is for educational and research purposes only, not a recommendation to buy or sell ENTG.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!